Lyme Persister Cells: Why Some Infections Resist Treatment

Borrelia can shift into more resistant forms
Standard antibiotics may not target all variants
Combination therapies show promise in laboratory studies

by Daniel J. Cameron, MD, MPH

In their study, “A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters,” Feng and colleagues describe how the Lyme bacterium can transform into “round body” or persister forms when exposed to stress such as antibiotics. :contentReference[oaicite:0]{index=0}

These variants appear more tolerant to commonly used antibiotics, raising important questions about treatment response in Lyme disease.

What Are Lyme Persister Cells?

Under stress, Borrelia burgdorferi can shift from its typical spiral form into round body and microcolony forms.

These forms have lower metabolic activity and increased tolerance to antibiotics—features that may contribute to persistent symptoms discussed in our persistent Lyme disease overview.

Why Standard Antibiotics May Be Less Effective

The study found that antibiotic tolerance increased as the bacteria transitioned from active growth to stationary phase, where persister forms dominate.

This may help explain why some patients continue to experience symptoms despite standard therapy—patterns reflected in our Lyme disease symptoms guide.

Promising Drug Combinations

Feng and colleagues identified drug combinations that were more effective than single-agent therapy in laboratory models.

The most active combination included:

• Daptomycin
• Doxycycline
• Cefoperazone

This combination eradicated highly resistant microcolony forms in vitro, with no regrowth observed after subculturing.

Additional drugs showing activity included artemisinin, ciprofloxacin, fosfomycin, and several sulfa-based agents.

What This Means for Treatment

These findings suggest that combination therapy may be necessary to target different bacterial forms.

However, it remains unclear how these results translate to clinical care, as further in vivo studies are needed.

Why This Matters

Lyme disease is a complex infection that may involve multiple bacterial forms and host responses.

This complexity contributes to ongoing discussions about treatment strategies and persistent symptoms, including those explored in our Lyme disease treatment options guide.

Understanding how Borrelia adapts under stress may help guide future therapies—but clinical decisions must be based on careful evaluation and evolving evidence.

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention